Plasma levels of asymmetric dimethylarginine in premature neonates: Its possible involvement in developmental programming of chronic diseases

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 3, 2009, Pages 437-441

  Vida, Gabriella ^a   Sulyok, Endre ^a   Lakatos, Orsolya ^a   Ertl, Tibor ^a   Martens Lobenhoffer, Jens ^b   Bode Böger, Stefanie M ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Asymmetric dimethylarginine; Developmental programming; Endothel dysfunction; Prematurity

Indexed keywords

ANTIBIOTIC AGENT; ARGININE; DEXAMETHASONE; DOPAMINE; N(G),N(G) DIMETHYLARGININE; OXYGEN; SURFACTANT;

ADULT; AMINO ACID BLOOD LEVEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BLOOD SAMPLING; CHRONIC DISEASE; CLINICAL ARTICLE; ENDOTHELIAL DYSFUNCTION; FEMALE; GESTATIONAL AGE; GLUCOSE INFUSION; HUMAN; INFECTION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NEWBORN; OXYGEN THERAPY; POSTNATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; VEIN PUNCTURE; VERY LOW BIRTH WEIGHT;

ARGININE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; METABOLIC SYNDROME X;

EID: 59149095475     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.01115.x     Document Type: Article

References (21)

1. Barker DJP. In utero programming of chronic disease. Clin Sci 1998 95 : 115 28.
2. Gluckman PD, Hanson MA, Pinal C. The developmental origins of adult disease. Matern Child Nutr 2005 1 : 130 41.
3. Barker DJP, Bagby SP, Hanson MA. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2007 2 : 700 7.
4. Rudolph AM. The fetal circulation and its response to stress. J Dev Physiol 1984 6 : 11 19.
5. Clark PM, Hindmarsh PC, Shiell AW, Law CM, Honour JW, Barker DJP. Size at birth and adrenocortical function in childhood. Clin Endocrinol 1996 45 : 721 6.
6. MacKenzie HS, Brenner BM. Fewer nephrons at birth: a missing link in the etiology of essential hypertension. Am J Kidney Dis 1995 26 : 91 8.
7. Vehaskari VM. Developmental origins of adult hypertension: new insights into the role of the kidney. Pediatr Nephrol 2007 22 : 490 5.
8. Hack M, Schluchter M, Cartar L, Ramman M. Blood pressure among very low birth weight (<1.5 kg) young adults. Pediatr Res 2005 58 : 677 84.
9. Boger RH, Bode-Böger SM. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost 2000 26 : 539 45.
10. Martens-Lobenhoffer J, Bode-Böger SM. Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 2006 52 : 488 93.
11. McBride AE, Silver PA. State of the arg: protein methylation at arginine comes of age. Cell 2001 106 : 5 8.
12. Maeda T, Yoshimusrat T, Okamure H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation. J Soc Gynecol Invest 2003 10 : 2 4.
13. van Den Berg A, Siroen MPC, Teerlink T, van Leeuwen PAM, Fetter WPF, van Elburg RM. Fetal concentrations of dimethylarginines in preeclampsia. Pediatr Res 2003 54 : 597 618.
14. Mittermayer F, Prusa AR, Pollak A, Wolzt M. Umbilical vein plasma concentrations of asymmetrical dimethylarginine are increased in male but not female neonates delivered preterm: a pilot study. Early Hum Develop 2006 82 : 421 4.
15. Vida G, Sulyok E, Ertl T, Martens-Lobenhoffer J, Bode-Böger S. Plasma asymmetric dimethylarginine concentration during the perinatal period. Neonatology 2007 92 : 8 13.
16. van Elburg RM, Richir M, Siroen MPC, Fetter WPF, Quik F, Nijveldt RJ, et al. Plasma concentrations of arginine and asymmetric dimethylarginine in premature infants: a possible explanation of necrotizing enterocolitis. Eur J Pediatr 2006 165 (Suppl 13 177.
17. Luo ZC, Fraser WD, Julien P, Deal CL, Audibert F, Smith GN, et al. Tracing the origins of "fetal origins" of adult diseases: Programming by oxidative stress? Med Hypoth 2006 66 : 38 44.
18. Sydow K, Münzel T. ADMA and oxidative stress. Atherosclerosis 2003 4 (Suppl 4 41 51.
19. Sulyok E, Németh M, Tényi I, Csaba IF, Varga L, Varga F. Relationship between the postnatal development of the renin-angiotensin- aldosterone system and electrolyte and acid-base status of the NaCl supplemented premature infants. In : Spitzer A, editor. The kidney during development; Morphology and function. Masson Publishing, New York, 1982 : 273 81.
20. Ito A, Egashira K, Narishige T, Muramatsu K, Takeshita A. Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus. Circ J 2002 66 : 811 15.
21. Wong C, Kanetsky P, Raj D. Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease. Pediatr Nephrol 2008 23 : 1037 51.